Literature DB >> 12484432

Rapid effects of olopatadine hydrochloride on the histamine-induced skin responses.

Keisuke Morita1, Tetsuya Koga, Yoichi Moroi, Kazunori Urabe, Masutaka Furue.   

Abstract

Olopatadine hydrochloride is one of the second-generation nonsedating antihistamines that are used for treating allergic disorders such as urticaria, rhinitis, and atopic dermatitis. We examined the inhibitory effects of this drug on the flare and wheal responses induced by histamine iontophoresis at 30, 60, and 90 min after oral administration in a double-blind, cross-over, and placebo-controlled study. Olopatadine hydrochloride significantly inhibited the histamine-induced flare and wheal responses as early as 60 min after oral administration when compared with placebo. Significant inihibitory effects of olopatadine hydrochloride on the itch responses were seen at 90 min after administration. Thus, olopatadine hydrochloride exhibited a very rapid and potent antihistamine effect on the histamine-induced skin responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484432     DOI: 10.1111/j.1346-8138.2002.tb00207.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

1.  Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.

Authors:  Manabu Tashiro; Hideki Mochizuki; Yumiko Sakurada; Kenji Ishii; Keiichi Oda; Yuichi Kimura; Toru Sasaki; Kiichi Ishiwata; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  Effects of olopatadine hydrochloride, a histamine h(1) receptor antagonist, on histamine-induced skin responses.

Authors:  Takashi Hashimoto; Norito Ishii; Takahiro Hamada; Teruki Dainichi; Tadashi Karashima; Takekuni Nakama; Shinichiro Yasumoto
Journal:  Dermatol Res Pract       Date:  2010-09-16

3.  Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria.

Authors:  Teruhiko Makino; Yoshiaki Takegami; Mati Ur Rehman; Yoko Yoshihisa; Waka Ishida; Takashi Toyomoto; Tadamichi Shimizu
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-09-19

4.  Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.

Authors:  Hiroyuki Kamei; Ami Isaji; Yukihiro Noda; Kazuhiro Ishikawa; Koji Senzaki; Kiyofumi Yamada; Kazumitsu Sugiura; Yasushi Tomita; Toshitaka Nabeshima
Journal:  Arch Dermatol Res       Date:  2011-12-01       Impact factor: 3.017

5.  Olopatadine in chronic idiopathic urticaria.

Authors:  Kiran V Godse
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.